4//SEC Filing
Bejar Rafael 4
Accession 0001567619-21-016228
CIK 0000882361other
Filed
Aug 22, 8:00 PM ET
Accepted
Aug 23, 4:53 PM ET
Size
8.1 KB
Accession
0001567619-21-016228
Insider Transaction Report
Form 4
Bejar Rafael
Chief Medical Officer
Transactions
- Award
Performance Stock Option
2021-08-19+200,000→ 200,000 totalExercise: $2.35Exp: 2031-08-19→ Common Shares (200,000 underlying) - Award
Performance Stock Option
2021-08-19+200,000→ 200,000 totalExercise: $2.35Exp: 2031-08-19→ Common Shares (200,000 underlying)
Footnotes (3)
- [F1]The options were granted on August 19, 2021 and vest upon the earlier of (i) certain performance conditions or (ii) August 19, 2025, subject to Reporting Person's continued employment with the Issuer.
- [F2]Options vest in tranches connected with dose escalation trials.
- [F3]Options vest in connection with expansion trials.
Documents
Issuer
Aptose Biosciences Inc.
CIK 0000882361
Entity typeother
Related Parties
1- filerCIK 0001797382
Filing Metadata
- Form type
- 4
- Filed
- Aug 22, 8:00 PM ET
- Accepted
- Aug 23, 4:53 PM ET
- Size
- 8.1 KB